Lv1
30 积分 2023-06-29 加入
Efficacy and safety of peptide receptor radionuclide therapy in advanced foregut and hindgut neuroendocrine tumors: a real-world experience from a single institution
17天前
已完结
Efficacy and safety of peptide radionuclide therapy with 177Lu-DOTATATE in Japanese patients with advanced neuroendocrine neoplasm: a multicenter retrospective study (JON2203-N)
21天前
已完结
[177Lu]Lu-dota-tate versus sunitinib in patients with metastatic progressive neuroendocrine tumours of the pancreas (OCLURANDOM): a randomised, controlled, phase 2 trial
21天前
已完结
[177Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial
21天前
已完结
The pathology and diagnosis of cancer cachexia and a treatment insight from natural products: A review
1个月前
已完结
Impact of body composition, nutritional and inflammatory status on outcome of non-small cell lung cancer patients treated with immunotherapy
1个月前
已完结
Systemic metabolic crosstalk as driver of cancer cachexia
1个月前
已完结
Systemic health impact of cancer-associated extracellular vesicles and particles
1个月前
已完结
Gastric Cancer: A Review
1个月前
已完结
Innovations in cancer immunotherapy: A comprehensive overview of recent breakthroughs and future directions
2个月前
已完结
皖公网安备34019202002308
